stars 1 stars 2 stars 3

PhysioStim is a French preclinical CRO dedicated to cardiovascular pharmacology and electrophysiology from discovery stages to clinical development. Whatever the therapeutic areas, we ensure robust and valuable preclinical data on cardiac and vascular activities and secondary pharmacology to secure in-vivo development and bring new safe therapies to patients. Thanks to our predictive and translational models, we define the POC of drug discovery, we investigate secondary pharmacology with on and off-target liabilities, and we address the safety purpose to build and support your IND submission (with mandatory and not mandatory assays). Physiostim senior scientific team is evolving in a GLP environment, the reactivity and accuracy are our best “signature” for more than 20 years. Let’s bridge the preclinical gap together, for the success of your clinical applications.

PhysioStim Questions

The PhysioStim annual revenue was $3 million in 2026.

Richard Printemps is the Chief Scientific Officer of PhysioStim.

7 people are employed at PhysioStim.

PhysioStim is based in Castres, Occitanie.

The NAICS codes for PhysioStim are [54171, 541, 5417, 541714, 54].

The SIC codes for PhysioStim are [87, 873].

Top PhysioStim Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users